Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.

Autor: Tutusaus, Anna1,2 (AUTHOR) anna.tutusaus@iibb.csic.es, Sanduzzi-Zamparelli, Marco2,3,4,5 (AUTHOR) lboix@clinic.cat, Boix, Loreto2,3,4 (AUTHOR), Rider, Patricia1,6 (AUTHOR) patricia.rider@iibb.csic.es, Subías, Silvia1 (AUTHOR) pablo.garcia@iibb.csic.es, García de Frutos, Pablo1,7,8 (AUTHOR) anna.colell@iibb.csic.es, Colell, Anna1,9 (AUTHOR) montserrat.mari@iibb.csic.es, Marí, Montserrat1 (AUTHOR), Reig, María2,3,4,5 (AUTHOR) mreig1@clinic.cat, Morales, Albert1,2 (AUTHOR) mreig1@clinic.cat
Zdroj: Cancers. Apr2024, Vol. 16 Issue 8, p1491. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje